Reliance TB & HIV Control Programme A public - private partnership project May 31, 2007 Mumbai

1. Reliance TB & HIV Control Programme A public - private partnership project May 31, 2007 Mumbai Reliance Industries Limited

2. Coverage RIL - an Overview Our approach to CSR Reliance TB & HIV Control Programme

3. RIL – an overview

4. Revenues equivalent to 2.7% of India’s GDP 12% of India’s total exports 5.2% of Government of India’s indirect tax revenue 12.2% weighting in BSE Sensex Highest market capitalization for any private sector company Reliance – India’s Proxy Global Ranks (Fortune Global 500 ) India and Reliance Note: all figures for the financial year ended March 31, 2007 Reliance is mirroring India’s Growth

5. A Journey of Phenomenal Growth Demerger RPL Refinery In US$ million Fortune 500 Trevira Acquired KGD6 Discovery IPCL Acquired Refinery Commissioned Cracker Commissioned Polymers Manufacturing Polyester Manufacturing IPO

6. Our approach to CSR

7. Our CSR Policy • Create economic opportunities for millions through our business initiatives • Utilize energy resources in a responsible and efficient manner • Create and sustain diversity at the workplace • Encourage employees to volunteer and spend time for community activities • Encourage suppliers and contractors to conduct their operations in a socially and environmentally responsible manner • Deal with all RIL stakeholders in an ethical manner • Support the development of professional resources, through educational initiatives • Bring the benefits of modern medical care to the needy, through health care initiatives • Leverage financial, physical and organizational resources of Reliance for rescue and rehabilitation work during natural and man-made disasters We subscribe to the philosophy of co-existence - “Vasudhaiva Kutumbakam” - the whole world is one family

8. Our CSR approach • Stake in areas that are of critical importance to the nation • Healthcare • Education • Child welfare • Local infrastructure development • Grass root level needs are best understood by people who work and live with the locals • RIL Group’s manufacturing locations spread across the country. • The demographic profile and social issues differ with each location. • To address issues unique to each site, we have a dedicated (CSR) team at each sites • CSR initiatives through Public-Private-Partnerships • Dhirubhai Ambani Foundation Thrust is on improving quality of life of the surrounding communities near our manufacturing locations

9. Reliance TB & HIV Control Program A public - private partnership project The pentagon of hope love and care

10. DOTS TB, HIV and AIDS • DOTS TB, HIV and AIDS Centre (in fulfillment of the UN sponsored Millennium Development Goals Agenda) • The Reliance DOTS TB HIV and AIDS Therapy Centre– a public-private partnership, is a our initiative to combat TB, HIV and AIDS • Pilot started at Hazira in 2004 • Expanded to Jamnagar in 2005 • The Centre at Hazira offers financial assistance, counseling services, awareness programme, treatment, alternate therapies like yoga and pranayama, and also nutritional support to the underprivileged The DOTS TB, HIV and AIDS centre at Harira (Top), Jamanagar (Bottom)

11. Our Partners • At Hazira • RNTCP ( HEALTH COMMISSIONERATE-GOG) • CII (CONFEDERATION OF INDIAN INDUSTRY) • LVS ( LOK VIKAS SANSTHA- NGO- GACS) • GSNP+ ( GUJARAT STATE NETWORK OF PEOPLE LIVING WITH HIV & AIDS) • At Jamnagar • RNTCP ( HEALTH COMMISSIONERATE-GOG) • SHREE SARVODAY MAHILA UDYOG MANDAL • JDNP+ (JAMNAGAR NETWORK OF PEOPLE LIVING WITH HIV & AIDS)

12. Awareness is life

13. Monitoring and treating the positives

14. Current Status (28/05/2007)

15. Current Status (28/05/2007)

16. Child Adoption Scheme • 20 HIV + children have been adopted by the Reliance Ladies Club for educational and nutritional support. • Each Reliance family is linked to a HIV+/AIDS child’s family. • These families routinely meet and interact once a month. • Children are provided all their special nutritional requirements by the sister family.

17. Treatment outcomeof HAART n= 333 • Majority of patients started on HAART showed a overall improvement in terms of reduced morbidity and better quality of life. • Incidences of Opportunistic infections were reduced by 35 to 40%. • The group as an average reported increase in the body weight by 7.8% ( 5 to 6 Kgs) within the first 6 to 8 months of starting therapy. • Most of the patients showed average 10% to 30% increase in the CD4 cell count their absolute CD4 counts within 6-8 months.

18. Lifestyle Improvement • Under treatment patients are showing positive attitude towards life. • Hundreds of our patients who had given up their working lives on grounds of sickness and had turned dependents following development of AIDS have now returned to their respective professions. Some have taken up new and less strenuous jobs. • Being able to transform themselves into earning members of the society, boosts their confidence and gives them ability to afford nutritional and medical support.

19. Awards & Recognition • RIL received the UNAIDS Civil Society Awards 2006 in recognition of the company’s outstanding commitment and support to the national fight against HIV and AIDS on the occasion of World Aids Day - December 1, 2006 • RIL received the 6thTERI Corporate Award for Business Response to HIV/ AIDS 2007 in recognition of its Business Response for HIV / AIDS intervention in Indian industry on May 23, 2007

20. Future Plans • To replicate the Hazira / Jamnagar model at all Reliance manufacturing sites, petroleum outlets, across all touch points. • To develop a specific pediatric HIV management unit with in-patient admission facility • To develop a 10-bedded “Community Care Center” for admitting patients for initial treatment induction. • To co-ordinate and co-sponsor a post graduate HIV –Medicine course. • To provide second line treatment for patients resistant to first line therapy.

21. Growth is Life Thank You